Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
NCT00691171 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5234
Last updated 2015-04-15
Summary
The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.
Conditions
- GERD
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
James M Gill, MD, PhD · Delaware Valley Outcomes Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
More Related Trials
-
Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
NCT00963144 ·Status: COMPLETED
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)
NCT01019928 ·Status: COMPLETED ·Phase: PHASE2
-
Heartburn, Gastroesophageal Reflux Disease
NCT07268820 ·Status: RECRUITING ·Phase: PHASE4
-
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
NCT00901004 ·Status: COMPLETED
-
HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease
NCT00243724 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience
NCT01043185 ·Status: COMPLETED ·Phase: PHASE2
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
NCT00171483 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom Adapted Therapy in GERD Patients
NCT00343161 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
NCT00171418 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
NCT00561730 ·Status: COMPLETED
-
Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI
NCT00587275 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.
NCT00171457 ·Status: COMPLETED ·Phase: PHASE3
-
Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD
NCT02670642 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
NCT00524251 ·Status: COMPLETED
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00390390 ·Status: COMPLETED ·Phase: PHASE3
-
Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
NCT00688675 ·Status: COMPLETED
-
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
NCT00695838 ·Status: COMPLETED
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00389948 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
NCT06641375 ·Status: RECRUITING ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance
NCT01079884 ·Status: COMPLETED ·Phase: NA
-
Epithelial Damage in GERD
NCT01867931 ·Status: COMPLETED